What is the difference between germline and somatic testing for Ocular Melanoma

Ocular_melanomaMay 23, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Germline vs. Somatic Testing for Ocular Melanoma

Great question—understanding the difference between these two types of genetic testing is crucial for making informed decisions about your care. Let me break this down clearly.

What These Tests Measure

Germline Testing looks for mutations you were born with—genetic changes present in every cell of your body, inherited from your parents. These are part of your DNA from conception.

Somatic Testing looks for mutations that developed only in your tumor cells—genetic changes that occurred after birth, specific to the cancer itself, not in your normal cells.

Why This Distinction Matters for Treatment

According to expert guidance on personalized cancer care, somatic mutations take priority for treatment decisions. Here's why: Your tumor's specific genetic profile—what's actually driving the cancer growth—is what determines which therapies will work best against it. Even if you carry a germline mutation, your tumor may not have developed the same mutation, so the treatment implications can be different.

As explained in the CancerPatientLab webinars on personalized testing: "Somatic always trumps germline" when it comes to selecting therapy, because you're trying to kill the tumor. The somatic mutations in your cancer cells are what your oncologist will use to guide treatment selection.

Why Germline Testing Still Matters

However, germline testing is also important for different reasons:

  • Family implications: If you carry a germline mutation, your blood relatives may also carry it and could be at increased cancer risk
  • Screening and prevention: Knowing about inherited predisposition helps guide screening for other cancers
  • Your future health: It informs what other health risks you and your family members should monitor

The Testing Process

Ideally, your oncology team will recommend both tests at or near diagnosis:

  • Somatic testing from your tumor tissue (biopsy)
  • Germline testing from your blood

This gives you the complete picture needed for treatment planning and family counseling.

Questions to Ask Your Ocular Melanoma Team

  1. Have I had somatic (tumor) testing done? If so, what mutations were found, and which ones are actionable for treatment?
  2. Should I have germline testing? This helps determine if I carry inherited cancer predisposition genes.
  3. If I have germline mutations, should I see a genetic counselor? They can explain implications for my family and my own screening needs.
  4. How will my somatic test results guide my treatment options? This is the key question for your immediate care plan.
  5. Will my results be updated if my cancer changes or I develop resistance to treatment? Sometimes repeat testing is needed.

Important Context for Ocular Melanoma

While the webinar sources provided focus primarily on other cancer types, the fundamental principles of germline vs. somatic testing apply across all cancers, including ocular melanoma. Your ocular oncologist should be familiar with these distinctions and able to explain how they apply specifically to your case.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: